United States Intravenous Immunoglobulin Market Size, Growth Forecasts To 2033
The United States Intravenous Immunoglobulin Market is anticipated to exceed USD 12.95 Billion by 2033, growing at a CAGR of 7.54% from 2023 to 2033. The growing demand for immunoglobulin replacement therapies, new product approval for treatment, and adoption of home infusion therapy are driving the growth of the intravenous immunoglobulin market in the US.